Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134004) titled 'A randomized double-blind controlled trial of a dual orexin receptor antagonist for sleep improvement in patients with depressive episode of bipolar disorder' on Oct. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Hangzhou Seventh People's Hospital
Condition:
patients with depressive episode of bipolar disorder and comorbid sleep disturbances
Intervention:
Healthy Control Group:No intervention
Placebo Control Group:Placebo
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-20
Target Sample Size: Healthy Control Group:50;Placebo Control Group...